This test is most useful if any of these apply to you.
Nearly everyone carries traces of a plastic softener called DEHP, and this test tells you how much has recently entered your body. That matters because higher levels line up with real problems: trouble conceiving, pregnancy loss, and early signs of metabolic strain.
Unlike a chemical that builds up and lingers for years, this one clears within a day or two, so your result is a snapshot of recent exposure. That is exactly what makes it something you can act on.
MEOHP (mono-(2-ethyl-5-oxohexyl) phthalate) is not a chemical you encounter directly. It is one of the breakdown products your liver makes after you absorb DEHP (di-2-ethylhexyl phthalate), a plasticizer used to make plastics soft and flexible. Because DEHP itself is gone from your body within hours, measuring this metabolite is how researchers gauge how much you took in.
DEHP shows up in food packaging, plastic wrap, flooring, medical tubing, and some personal care products. For most people, diet is the main route, especially packaged, processed, or plastic-wrapped foods. This metabolite is detectable in more than 90% of the general population, so the question is rarely whether you have any, but how much.
There is a practical reason this particular metabolite is used instead of the simpler one (called MEHP). MEOHP and its close sister metabolite MEHHP appear in urine at roughly 5 to 10 times higher levels than MEHP and track very closely together, and they are less likely to be thrown off by stray plastic contamination during sample handling. That makes them the more sensitive and reliable read on DEHP exposure.
One honesty check up front: this is a research and exposure marker, not an established clinical test with agreed-upon cutoffs. There is no standardized "normal" or "optimal" number, and a single reading should not drive a medical decision on its own. Its value comes from seeing your level, understanding the sources, and tracking whether it moves.
The strongest human signal for this metabolite is reproductive. In a case-control study of Jordanian women, higher urinary MEOHP was linked to about 66% higher odds of infertility (adjusted odds ratio 1.66) after accounting for other factors. In a large Chinese pregnancy cohort, higher MEOHP was among the metabolites tied to greater risk of clinical pregnancy loss, particularly early embryonic loss.
Fertility treatment data point the same direction. Among women undergoing in vitro fertilization, those in the highest exposure group for combined DEHP metabolites had roughly 19 percentage points lower rates of clinical pregnancy and live birth than those in the lowest group, along with fewer eggs retrieved. A separate pregnancy study found that women in the highest tier of MEHHP (the sister metabolite, not MEOHP specifically) had about twice the odds of miscarriage as those in the lowest tier.
What this means for you: if you are trying to conceive or preparing for IVF, an elevated level flags a modifiable exposure you can reduce before and during conception, and it gives you a way to confirm those changes are working.
Higher DEHP metabolites cluster with metabolic trouble across several populations. In a study of 1,124 Spanish male workers, higher MEOHP was tied to roughly 25% higher odds of general obesity (odds ratio 1.24), with the summed DEHP metabolites and MEHHP showing similar increases. In a panel study of older Korean adults, higher summed DEHP metabolites were associated with more insulin resistance, meaning the body responds less efficiently to its own blood-sugar hormone.
The pattern extends to the liver and blood fats. In an analysis of 3,137 US adults, higher phthalate exposure including DEHP metabolites was linked to greater risk of metabolic dysfunction-associated fatty liver disease (fat buildup in the liver driven by metabolic strain). In a separate US analysis of over 9,000 adults, people in the highest MEOHP group had lower protective HDL cholesterol and higher triglycerides than those in the lowest group.
These are observational associations, not proof that the chemical causes the conditions. Still, if you are working on weight, blood sugar, or a fatty liver, this marker may reveal one environmental contributor that standard metabolic labs do not capture.
A meta-analysis of DEHP and thyroid function found that higher MEOHP was weakly linked to higher levels of thyroid-stimulating hormone, the pituitary signal that rises when the thyroid is under strain. The effect was small (a pooled correlation of about 0.02, where 1.0 would be a perfect link), so this is a subtle nudge rather than a clear thyroid problem.
Other human studies connect higher DEHP metabolites to airway inflammation and reduced lung function in asthmatic children, to higher blood levels of neurofilament light chain (a protein that leaks out when nerve fibers are injured) in US adults, and to more behavior problems in children whose mothers had higher prenatal exposure. These findings are individually modest and mostly cross-sectional, but together they explain why chronic exposure draws concern.
This is the single most important thing to understand about interpreting your result. The lab can measure the metabolite precisely (repeat runs on the same sample vary by only about 10%), but your body's level swings a lot from day to day. When researchers measured the same person repeatedly over weeks to months, agreement was generally poor (a reproducibility score usually in the range of about 0.1 to 0.3 for DEHP metabolites, where 1.0 would mean perfectly stable).
The reason is simple: the number reflects what you ate and touched in the last day or two, not a stable body store. A single spot sample only partly represents your usual exposure, and averaging several samples over time gives a far more honest picture. This is why a trend beats any one snapshot.
A sensible cadence: get a baseline, then retest 4 to 8 weeks after you change your food and product habits to see whether the number actually dropped, and then at least annually to keep tabs. Because this is a newer measurement without standardized cutoffs, building your own history is exactly what gives the result meaning. You will have your own before-and-after to compare against.
Because this metabolite reflects only the last day or two, a few recent activities can distort a single reading:
A high reading is not a diagnosis. The first move is to confirm it is not a fluke: repeat the test with a first-morning sample on a normal day, and ideally add a second sample a few weeks later. Consistency across samples means more than any single spike.
For context, it helps to look at your broader exposure picture rather than this one metabolite in isolation. A panel that also measures other phthalate breakdown products and bisphenol A (another common plastic-related chemical) shows whether you have a general exposure problem or a single dominant source. If you are trying to conceive or going through fertility treatment, share elevated results with a reproductive specialist, since the reproductive evidence is where the signal is strongest. If your concern is metabolic, pair this with your standard blood-sugar, lipid, and liver markers so you can weigh exposure alongside the rest of the picture.
Evidence-backed interventions that affect your MEOHP level
Mono-(2-ethyl-5-oxohexyl) Phthalate is best interpreted alongside these tests.
Mono-(2-ethyl-5-oxohexyl) Phthalate is included in these pre-built panels.